Security
Beyond Air, Inc. Common Stock · XAIR
XAIRNASDAQCommon stockCurrentCIK 1641631Updated Oct 3, 2026
Name history
AIT Therapeutics, Inc. · through Jun 18, 2019KokiCare, Inc. · through Dec 16, 2016
XAIR price & chart
Loading TradingView…
NASDAQ:XAIR on TradingView ↗In the news
Beyond Air Schedules Fiscal Year End 2026 Financial Results Conference Call and Webcast ↗
Recent filings
Entry into a Material Definitive Agreement · Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
Items 1.01, 5.02, 9.01
EFFECT filing
424B3 filing
Results of Operations and Financial Condition · Regulation FD Disclosure
Items 2.02, 7.01, 9.01
S-3 filing
Show 5 more recent filings
Financials
FY 2026 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 35,385,000Source | 30,062,000Source | 56,961,000Source | 68,749,000Source |
| Property, Plant and Equipment, NetUSD | 8,249,000Source | 11,013,000Source | 9,364,000Source | 5,003,000Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 6,740,000Source | 4,665,000Source | 11,378,000Source | 29,158,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 1,086,000Source | 710,000Source | 319,000Source | — |
| Inventory, NetUSD | 1,406,000Source | 2,417,000Source | 2,127,000Source | 1,129,000Source |
| Assets, CurrentUSD | 24,767,000Source | 16,018,000Source | 43,936,000Source | 59,410,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 5,012,000Source | 5,743,000Source | 6,792,000Source | 1,850,000Source |
| Operating Lease, Right-of-Use AssetUSD | 1,193,000Source | 1,706,000Source | 2,121,000Source | 2,493,000Source |
| Other Assets, NoncurrentUSD | 158,000Source | 103,000Source | 113,000Source | 212,000Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 29,175,000Source | 15,721,000Source | 29,775,000Source | 26,721,000Source |
| Stockholders’ equity: | ||||
| Common Stock, Value, IssuedUSD | 1,000Source | 8,000Source | 5,000Source | 3,000Source |
| Additional Paid in CapitalUSD | 325,587,000Source | 299,982,000Source | 264,780,000Source | 217,339,000Source |
| Retained Earnings (Accumulated Deficit)USD | -319,571,000Source | -286,322,000Source | -239,697,000Source | -179,455,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | 134,000Source | -60,000Source | -15,000Source | 53,000Source |
| Stockholders' Equity Attributable to ParentUSD | 6,126,000Source | 13,583,000Source | 25,048,000Source | 37,915,000Source |
| Liabilities and EquityUSD | 35,385,000Source | 30,062,000Source | 56,961,000Source | 68,749,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 6,511,000Source | 5,000,000Source | 11,567,000Source | 19,780,000Source |
| Operating Lease, Liability, CurrentUSD | 321,000Source | 396,000Source | 418,000Source | 376,000Source |
| Accounts Payable, CurrentUSD | 2,417,000Source | 1,950,000Source | 1,948,000Source | 2,016,000Source |
| Operating Lease, Liability, NoncurrentUSD | 1,023,000Source | 1,486,000Source | 1,898,000Source | 2,321,000Source |
| Stockholders' Equity Attributable to Noncontrolling InterestUSD | 84,000Source | 758,000Source | 2,138,000Source | 4,113,000Source |
| Additional Financial Items | ||||
| Accrued Liabilities, CurrentUSD | — | — | — | 16,613,000Source |
| Cash, Cash Equivalents, and Short-term InvestmentsUSD | 17,263,000Source | 7,148,000Source | 34,698,000Source | 56,011,000Source |
| Deferred Revenue, CurrentUSD | 777,000Source | — | — | — |
| Long-term DebtUSD | — | — | 17,500,000Source | 200,000Source |
cash flow · annual statements
| Line item | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | -34,334,000Source | -48,479,000Source | -64,295,000Source | -59,401,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation and amortization | — | — | — | — |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 5,282,000Source | 9,146,000Source | 21,337,000Source | 19,558,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | 468,000Source | 390,000Source | 319,000Source | — |
| Increase (Decrease) in InventoriesUSD | -1,110,000Source | 466,000Source | 998,000Source | 781,000Source |
| Increase (Decrease) in Accounts PayableUSD | 267,000Source | 399,000Source | -467,000Source | 838,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -18,144,000Source | -38,218,000Source | -56,014,000Source | -33,009,000Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -3,674,000Source | 14,905,000Source | -12,235,000Source | -20,587,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 1,025,000Source | 5,883,000Source | 5,745,000Source | 3,877,000Source |
| Cash flows from financing activities: | ||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 29,090,000Source | 16,646,000Source | 43,167,000Source | 2,696,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | 7,466,000Source | -6,712,000Source | -25,160,000Source | -50,944,000Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 423,000Source | 1,197,000Source | 1,759,000Source | 36,000Source |
| Additional Financial Items | ||||
| Amortization of Debt Issuance Costs and DiscountsUSD | 551,000Source | 1,028,000Source | 1,150,000Source | — |
| Amortization of Intangible AssetsUSD | 204,000Source | 205,000Source | 205,000Source | 205,000Source |
| Cash, Cash Equivalents, and Short-term InvestmentsUSD | 17,263,000Source | 7,148,000Source | 34,698,000Source | 56,011,000Source |
| DepreciationUSD | 3,047,000Source | 2,999,000Source | 1,775,000Source | — |
| Derivative, Gain (Loss) on Derivative, NetUSD | -1,395,000Source | 1,314,000Source | — | — |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | -108,000Source | -3,000Source | -6,000Source | -105,000Source |
| Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber PropertyUSD | -431,000Source | -334,000Source | — | — |
| Gain (Loss) on Disposition of AssetsUSD | -431,000Source | -738,000Source | — | — |
| Gain (Loss) on Extinguishment of DebtUSD | -165,000Source | -2,447,000Source | — | — |
| General and Administrative ExpenseUSD | — | — | 37,337,000Source | 34,694,000Source |
| InterestExpenseNonoperatingUSD | 3,515,000Source | 3,019,000Source | — | — |
| Inventory Write-downUSD | 672,000Source | — | — | — |
| Marketable Securities, Unrealized Gain (Loss)USD | — | -60,000Source | -123,000Source | 12,000Source |
| Net Income (Loss) Attributable to ParentUSD | -33,249,000Source | -46,625,000Source | -60,242,000Source | -55,816,000Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | -1,085,000Source | -1,854,000Source | -4,053,000Source | -3,585,000Source |
| Nonoperating Income (Expense)USD | -5,290,000Source | -3,942,000Source | -1,288,000Source | -7,342,000Source |
| Operating ExpensesUSD | 29,296,000Source | 42,874,000Source | 61,700,000Source | 51,504,000Source |
| Other Nonoperating Income (Expense)USD | -14,000Source | 9,000Source | — | — |
| Proceeds from Issuance of Common StockUSD | 4,500,000Source | 18,858,000Source | — | — |
| Proceeds from Stock Options ExercisedUSD | — | — | 217,000Source | — |
income statement · annual statements
| Line item | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Total RevenueUSD | 7,679,000Source | 3,705,000Source | 1,159,000Source | — |
| Cost of Goods and Services Sold | — | — | — | — |
| Selling, General and Administrative ExpenseUSD | 19,055,000Source | 26,017,000Source | — | — |
| Operating Income (Loss)USD | -29,044,000Source | -44,537,000Source | -63,006,000Source | -52,059,000Source |
| Other Nonoperating Income (Expense)USD | -14,000Source | 9,000Source | — | — |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | -34,334,000Source | -48,479,000Source | -64,295,000Source | -59,401,000Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | -1,085,000Source | -1,854,000Source | -4,053,000Source | -3,585,000Source |
| Net Income (Loss) Attributable to ParentUSD | -33,249,000Source | -46,625,000Source | -60,242,000Source | -55,816,000Source |
| Earnings Per Share, BasicUSD per share | -4.01Source | -0.69Source | -1.82Source | -1.86Source |
| Earnings Per Share, DilutedUSD per share | -4.01Source | -0.69Source | -1.82Source | — |
| Weighted Average Number of Shares Outstanding, Basicshares | 8,300,916Source | 67,706,527Source | 33,160,180Source | 29,973,639Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 8,300,916Source | 67,706,527Source | 33,160,180Source | — |
| Interest Expense (non-operating)USD | 3,515,000Source | 3,019,000Source | — | — |
| Additional Financial Items | ||||
| Amortization of Intangible AssetsUSD | 204,000Source | 205,000Source | 205,000Source | 205,000Source |
| Depreciation, Depletion and Amortization, NonproductionUSD | 3,100,000Source | 3,000,000Source | 1,800,000Source | 634,000Source |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | -108,000Source | -3,000Source | -6,000Source | -105,000Source |
| General and Administrative ExpenseUSD | — | — | 37,337,000Source | 34,694,000Source |
| Gross ProfitUSD | 252,000Source | -1,663,000Source | -1,307,000Source | -555,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | -27,066,000Source | -42,186,000Source | -54,757,000Source | -49,720,000Source |
| Interest ExpenseUSD | — | — | 2,912,000Source | 30,000Source |
| Nonoperating Income (Expense)USD | -5,290,000Source | -3,942,000Source | -1,288,000Source | -7,342,000Source |
| Operating ExpensesUSD | 29,296,000Source | 42,874,000Source | 61,700,000Source | 51,504,000Source |
| Research and Development ExpenseUSD | 10,241,000Source | 16,857,000Source | 24,363,000Source | 16,810,000Source |
Offerings
Registration 333-298387
Filing attachments
ex99-1.htm · 8-K · 2026-08-18
EX-99.1 2 ex99-1.htm EX-99.1 Exhibit 99.1 Beyond Air® Reports Financial Results for the Quarter Ended June 30, 2026 and Provides Corporate Update Reports $1.8 million revenue for quarter ended June 30, 2026; reaffirms revenue guidance of $8 million for CY2026 and $16-$18 million for CY2027 PMA supplement for second-generation LungFit PH system under FDA review; approval expected in 2H CY2026 Recent financing up to $30.1 million to support ongoing international expansion and U.S. commerci…
Read attachment ↗ex107.htm · S-3 · 2026-08-17
Calculation of Filing Fee Tables S-3 Beyond Air, Inc. ──────────────────────────────────── Table 1: Newly Registered and Carry Forward Securities ☐Not Applicable ─────────────────────────────────────────────────────────────────────────────── Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Pri…
Read attachment ↗ex4-1.htm · 8-K · 2026-07-31
EX-4.1 2 ex4-1.htm EX-4.1 Exhibit 4.1 THIS WARRANT AND THE SHARES OF COMMON STOCK ISSUABLE UPON THE EXERCISE OF THIS WARRANT (THE “SECURITIES”) HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR THE SECURITIES LAWS OF ANY STATE OF THE UNITED STATES. THE SECURITIES HAVE BEEN ACQUIRED FOR INVESTMENT AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED UNLESS (I) SUCH SECURITIES HAVE BEEN REGISTERED FOR SALE PURSUANT TO THE SECURITIES ACT, (II) SUCH SECURI…
Read attachment ↗ex4-2.htm · 8-K · 2026-07-31
EX-4.2 3 ex4-2.htm EX-4.2 Exhibit 4.2 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE …
Read attachment ↗ex4-3.htm · 8-K · 2026-07-31
EX-4.3 4 ex4-3.htm EX-4.3 Exhibit 4.3 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE …
Read attachment ↗ex99-1.htm · 8-K · 2026-07-31
EX-99.1 7 ex99-1.htm EX-99.1 Exhibit 99.1 Beyond Air® Announces Up to $30.1 Million Private Placement Offering Priced At-the-Market Under Nasdaq Rules Beyond Air™ $10.2 million upfront with up to $10.0 million of short-term warrants, accelerated upon FDA clearance; financing also includes an additional $10.0 million in long-term warrants GARDEN CITY, N.Y., July 30, 2026 (GLOBE NEWSWIRE) - Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial-stage medical device a…
Read attachment ↗